The Prescription Drug Price Relief Act of 2025 is designed to reduce the cost of prescription medications in the United States by addressing the issue of excessive drug pricing. The legislation seeks to dismantle government-supported monopolies that enable pharmaceutical companies to set prices significantly higher than those in other countries. To achieve this, the law establishes a systematic approach for identifying overpriced drugs.